Både minor blødning og major blødning var signifikant mindre hyppig i bivalirudingruppen end i heparin - + GPIIb/ IIIa- inhibitor- gruppen.
Both minor and major bleeds were significantly less frequent with bivalirudin than the heparin plus GPIIb/ IIIa inhibitor comparator group.